Alzheimer’s disease;clinical trial;lecanemab;aducanumab

Small Percentage of People with Early Dementia Eligible for New Alzheimer’s Drugs

[ad_1] EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, AUGUST 16, 2023 Newswise — MINNEAPOLIS – Only a small percentage…